Congratulations to Christine Seroogy, MD, on funding of $40,000 from the UW Paul P. Carbone Cancer Center (UWCCC) and the Tumor Microenvironment Program. Her project, “The Role of the Anergy-related E3 ubiquitin ligase, GRAIL, in Tumor Immune Evasion,” utilizes mice to further understanding of the role of GRAIL in tumor immune evasion, in hopes of providing further insights into proteasome inhibitor mechanisms of action and pursuing combinatorial therapies.